Skip to main content
. 2023 Jan 10;29(11):1730–1740. doi: 10.1093/ibd/izac269

Figure 2.

Figure 2.

Kaplan-Meier time-to-relapse curve showing the relapse of inflammatory bowel disease at 6 and 12 months after vedolizumab discontinuation. CD, Crohn’s disease; UC, ulcerative colitis.